Predicting the severity of relapsing-remitting MS: the contribution of cross-sectional and short-term follow-up MRI data (Q33791632)

29 July 2017

Predicting the severity of relapsing-remitting MS: the contribution of cross-sectional and short-term follow-up MRI data (English)

1 reference

29 July 2017

8

F Fazekas

1 reference

29 July 2017

C Enzinger

1

1 reference

29 July 2017

S Fuchs

2

1 reference

29 July 2017

A Pichler

3

1 reference

29 July 2017

M Wallner-Blazek

4

1 reference

29 July 2017

M Khalil

5

1 reference

29 July 2017

C Langkammer

6

1 reference

29 July 2017

S Ropele

7

1 reference

29 July 2017

12 January 2011

1 reference

Multiple Sclerosis Journal

29 July 2017

1 reference

29 July 2017

17

1 reference

29 July 2017

6

1 reference

29 July 2017

695-701

1 reference

Clinically isolated syndromes: predicting and delaying multiple sclerosis

29 July 2017

1 reference

https://api.crossref.org/works/10.1177%2F1352458510394454

MRI characteristics are predictive for CDMS in monofocal, but not in multifocal patients with a clinically isolated syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510394454

Brain atrophy and lesion load measures over 1 year relate to clinical status after 6 years in patients with clinically isolated syndromes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510394454

A 6-year clinical and MRI follow-up study of patients with relapsing-remitting multiple sclerosis treated with Interferon-beta.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510394454

Eight-year follow-up study of brain atrophy in patients with MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510394454

Predicting clinical progression in multiple sclerosis with the magnetic resonance disease severity scale.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510394454

Significance of T2 lesions in multiple sclerosis: A 13-year longitudinal study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510394454

Association between MRI parameters and the MS severity scale: a 12 year follow-up study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510394454

Accelerated evolution of brain atrophy and "black holes" in MS patients with APOE-epsilon 4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510394454

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510394454

Defining the clinical course of multiple sclerosis: Results of an international survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510394454

Risk factors for progression of brain atrophy in aging: six-year follow-up of normal subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510394454

Multiple Sclerosis Severity Score: using disability and disease duration to rate disease severity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510394454

Accumulation of hypointense lesions ("black holes") on T1 spin-echo MRI correlates with disease progression in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510394454

Hypointense lesions on T1-weighted spin-echo magnetic resonance imaging: relation to clinical characteristics in subgroups of patients with multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510394454

Brain atrophy and lesion load in a large population of patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510394454

Assessing brain atrophy rates in a large population of untreated multiple sclerosis subtypes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510394454

White matter lesion progression, brain atrophy, and cognitive decline: the Austrian stroke prevention study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510394454

Agreement between different input image types in brain atrophy measurement in multiple sclerosis using SIENAX and SIENA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510394454

Magnetization transfer can predict clinical evolution in patients with multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510394454

Spinal cord lesions and clinical status in multiple sclerosis: A 1.5 T and 3 T MRI study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510394454

Can the Expanded Disability Status Scale be assessed by telephone?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510394454

Defining the response to interferon-β in relapsing-remitting multiple sclerosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510394454

21 January 2018

Identifiers

DOI

10.1177/1352458510394454

1 reference

29 July 2017

1 reference